Evid Invest
Who owns DYNWhat DYN owns — n/a

Who owns Dyne Therapeutics, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of DYN from SEC Form 13F filings across 269 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 269 institutions disclosed 213.6M shares of Dyne Therapeutics, Inc. worth $3.45B — about 129.1% of shares outstanding; the largest disclosed holder is T. Rowe Price Investment Management, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.

269

13F holders

$3.45B

value, 2026 filers

129.1%

of shares outstanding (213.6M sh)

62

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of DYN's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1T. Rowe Price Investment Management, Inc.34.3M$552.1M0.4%20.7%+10.9%
2BlackRock, Inc.14.5M$233.1M0.0%8.7%+16.7%
3Janus Henderson Group Ltd.NEW12.0M$193.9M0.1%7.3%new
4FMR LLC11.1M$179.6M0.0%6.7%-0.5%
5WELLINGTON MANAGEMENT GROUP LLP10.6M$170.4M0.0%6.4%+20080.3%
6STATE STREET CORP8.2M$131.4M0.0%4.9%+9.4%
7VANGUARD CAPITAL MANAGEMENT LLC7.6M$121.7M0.0%4.6%+19.7%
8Orbis Allan Gray Ltd7.3M$118.1M0.4%4.4%+4.7%
9Vestal Point Capital, LP6.2M$99.9M2.6%3.7%+83.7%
10VANGUARD PORTFOLIO MANAGEMENT LLC4.7M$75.6M0.0%2.8%+15.9%
11TCG Crossover Management, LLC4.6M$74.3M2.1%2.8%0.0%
12GEODE CAPITAL MANAGEMENT, LLC4.4M$70.8M0.0%2.7%+17.4%
13Frazier Life Sciences Management, L.P.3.9M$62.1M1.5%2.3%+22.2%
14PRICE T ROWE ASSOCIATES INC /MD/3.7M$60.0M0.0%2.3%-5.4%
15FCPM III SERVICES B.V.3.6M$57.8M5.4%2.2%-6.8%
16Atlas Venture Life Science Advisors, LLC3.4M$55.4M8.8%2.1%-49.4%
17MPM BIOIMPACT LLC3.2M$51.7M3.8%1.9%+66.9%
18Logos Global Management LP3.0M$48.3M2.6%1.8%+17.6%
19JPMORGAN CHASE & CO2.9M$47.4M0.0%1.8%-7.6%
20ARMISTICE CAPITAL, LLC2.7M$43.1M0.5%1.6%-13.3%
21BANK OF AMERICA CORP /DE/2.6M$41.2M0.0%1.5%+14.4%
22Sofinnova Investments, Inc.2.5M$40.5M1.8%1.5%+51.4%
23Siren, L.L.C.2.4M$39.1M0.9%1.5%+14.1%
24Polar Capital Holdings Plc2.3M$36.6M0.1%1.4%+76.5%
25Venrock Adviser, LLC2.2M$35.0M1.7%1.3%0.0%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.